Background: Over the last decades, research on early life risk factors for obesity and its comorbidities in early life has gained attention within the field of developmental origins of health and diseases. Metabolomics studies that are trying to find early life biomarker and intervention targets for the early development of obesity and associated cardiovascular diseases could help break the inter-generational cycle of obesity. Summary: Metabolomics studies in the field of early programming are scarce and causality is lacking at this stage, as most of the studies are cross-sectional. The main metabolites in the focus of obesity are branched-chain and aromatic amino acids, long-chain polyunsaturated fatty acids, lysophosphatidylcholines, and sphingomyelins. Sex and puberty have not been considered in most of the biomarker studies, but show differences in the metabolite associations to obesity. Key Messages: There is still a lot unknown about the associations between early programming exposures, metabolite concentrations, and the development of obesity. The few studies focusing on this topic find similar metabolite classes in the same age groups being associated with rapid early growth or obesity; but due to differences in the methodological and statistical approaches, the single species often differ. Therefore, more research, preferably with standardized approaches, is needed.

Keywords:
Sphingomyelin, Metabolomics, Obesity, Branched-chain amino acids, Long-chain polyunsaturated fatty acids, Puberty, Sex differences, Developmental origins of health and diseases
1.
Dörner G: Perinatal Hormone Levels and Brain Organization. Anatomical Neuroendocrinology. Karger Publishers, 1975, pp 245-252.
2.
NCD Risk Factor Collaboration (NCD-Risc): Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19 2 million participants. Lancet 2016;387:1377-1396.
3.
Martin-Gronert MS, Ozanne SE: Early life programming of obesity. Med Wieku Rozwoj 2013;17:7-12.
4.
Von Kries R, Koletzko B, Sauerwald T, Von Mutius E, Barnert D, Grunert V, et al: Breast feeding and obesity: cross sectional study. BMJ 1999;319:147-150.
5.
Gillman MW, Ludwig DS: How early should obesity prevention start? N Engl J Med 2013;369:2173-2175.
6.
Qiao Y, Ma J, Wang Y, Li W, Katzmarzyk PT, Chaput JP, et al: Birth weight and childhood obesity: a 12-country study. Int J Obes Suppl 2015;5(suppl 2):S74-S79.
7.
Steur M, Smit HA, Schipper CM, Scholtens S, Kerkhof M, de Jongste JC, et al: Predicting the risk of newborn children to become overweight later in childhood: the PIAMA birth cohort study. Int J Pediatr Obes 2011;6:e170-e178.
8.
Biosca M, Rodriguez G, Ventura P, Samper MP, Labayen I, Collado MP, et al: Central adiposity in children born small and large for gestational age. Nutr Hosp 2011;26:971-976.
9.
Dolan MS, Sorkin JD, Hoffman DJ: Birth weight is inversely associated with central adipose tissue in healthy children and adolescents. Obesity (Silver Spring) 2007;15:1600-1608.
10.
Heerwagen MJ, Miller MR, Barbour LA, Friedman JE: Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 2010;299:R711-R722.
11.
Berglund SK, Garcia-Valdes L, Torres-Espinola FJ, Segura MT, Martinez-Zaldivar C, Aguilar MJ, et al: Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE). BMC Public Health 2016;16:207.
12.
Tabibzadeh P, Mewes R: Thin mother, obese child? A review of early risk factors for obesity in offspring. Curr Opin Psychiatry 2016;29:309-315.
13.
Sircar M, Thadhani R, Karumanchi SA: Pathogenesis of preeclampsia. Curr Opin Nephrol Hypertens 2015;24:131-138.
14.
Lindsay KL, Hellmuth C, Uhl O, Buss C, Wadhwa PD, Koletzko B, et al: Longitudinal metabolomic profiling of amino acids and lipids across healthy pregnancy. PLoS One 2015;10:e0145794.
15.
Donahue SM, Rifas-Shiman SL, Gold DR, Jouni ZE, Gillman MW, Oken E: Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort. Am J Clin Nutr 2011;93:780-788.
16.
Moon RJ, Harvey NC, Robinson SM, Ntani G, Davies JH, Inskip HM, et al: Maternal plasma polyunsaturated fatty acid status in late pregnancy is associated with offspring body composition in childhood. J Clin Endocrinol Metab 2013;98:299-307.
17.
de Vries PS, Gielen M, Rizopoulos D, Rump P, Godschalk R, Hornstra G, et al: Association between polyunsaturated fatty acid concentrations in maternal plasma phospholipids during pregnancy and offspring adiposity at age 7: the MEFAB cohort. Prostaglandins Leukot Essent Fatty Acids 2014;91:81-85.
18.
Vidakovic AJ, Gishti O, Voortman T, Felix JF, Williams MA, Hofman A, et al: Maternal plasma PUFA concentrations during pregnancy and childhood adiposity: the Generation R Study. Am J Clin Nutr 2016;103:1017-1025.
19.
Brei C, Stecher L, Much D, Karla MT, Amann-Gassner U, Shen J, et al: Reduction of the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on offspring body composition: follow-up results from a randomized controlled trial up to 5 y of age. Am J Clin Nutr 2016;103:1472-1481.
20.
Muhlhausler BS, Yelland LN, McDermott R, Tapsell L, McPhee A, Gibson RA, et al: DHA supplementation during pregnancy does not reduce BMI or body fat mass in children: follow-up of the DHA to optimize mother infant outcome randomized controlled trial. Am J Clin Nutr 2016;103:1489-1496.
21.
Hellmuth C, Lindsay KL, Uhl O, Buss C, Wadhwa PD, Koletzko B, et al: Association of maternal prepregnancy BMI with metabolomic profile across gestation. Int J Obes (Lond) 2017;41:159-169.
22.
Larque E, Pagan A, Prieto MT, Blanco JE, Gil-Sanchez A, Zornoza-Moreno M, et al: Placental fatty acid transfer: a key factor in fetal growth. Ann Nutr Metab 2014;64:247-253.
23.
Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, Graf K, Vetter K, Abou-Dakn M, et al: Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med 2011;28:1053-1059.
24.
Uhl O, Demmelmair H, Segura MT, Florido J, Rueda R, Campoy C, et al: Effects of obesity and gestational diabetes mellitus on placental phospholipids. Diabetes Res Clin Pract 2015;109:364-371.
25.
Pagan A, Prieto-Sanchez MT, Blanco-Carnero JE, Gil-Sanchez A, Parrilla JJ, Demmelmair H, et al: Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. Am J Physiol Endocrinol Metab 2013;305:E826-E833.
26.
Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, et al: Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 2014;509:503-506.
27.
Prieto-Sanchez MT, Ruiz-Palacios M, Blanco-Carnero JE, Pagan A, Hellmuth C, Uhl O, et al: Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes. Clin Nutr 2016;pii:S0261-5614(16)00036-4.
28.
Isganaitis E, Rifas-Shiman SL, Oken E, Dreyfuss JM, Gall W, Gillman MW, et al: Associations of cord blood metabolites with early childhood obesity risk. Int J Obes (Lond) 2015;39:1041-1048.
29.
Standl M, Demmelmair H, Koletzko B, Heinrich J: Cord blood n-3 LC-PUFA is associated with adiponectin concentrations at 10 years of age. Prostaglandins Leukot Essent Fatty Acids 2015;96:51-55.
30.
Hellmuth C, Uhl O, Standl M, Demmlmair H, Heinrich J, Koletzko B, et al: Cord blood metabolome is highly associated with birth weight, but less predictive for later weight development. Obes Facts 2017, in press.
31.
Koletzko B, von Kries R, Closa R, Escribano J, Scaglioni S, Giovannini M, et al: Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr 2009;89:1836-1845.
32.
Weber M, Grote V, Closa-Monasterolo R, Escribano J, Langhendries JP, Dain E, et al: Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. Am J Clin Nutr 2014;99:1041-1051.
33.
Kirchberg FF, Harder U, Weber M, Grote V, Demmelmair H, Peissner W, et al: Dietary protein intake affects amino acid and acylcarnitine metabolism in infants aged 6 months. J Clin Endocrinol Metab 2014;100:149-158.
34.
Socha P, Grote V, Gruszfeld D, Janas R, Demmelmair H, Closa-Monasterolo R, et al: Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. Am J Clin Nutr 2011;94(6 suppl):1776S-1784S.
35.
Brosnan JT, Brosnan ME: Branched-chain amino acids: enzyme and substrate regulation. J Nutr 2006;136(1 suppl):207S-211S.
36.
Karlsland Akeson PM, Axelsson IE, Räihä NC: Protein and amino acid metabolism in three-to twelve-month-old infants fed human milk or formulas with varying protein concentrations. J Pediatr Gastroenterol Nutr 1998;26:297-304.
37.
Rzehak P, Hellmuth C, Uhl O, Kirchberg FF, Peissner W, Harder U, et al: Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Ann Nutr Metab 2014;64:294-303.
38.
Fleddermann M, Demmelmair H, Grote V, Bidlingmaier M, Grimminger P, Bielohuby M, et al: Role of selected amino acids on plasma IGF-I concentration in infants. Eur J Nutr 2015, Epub ahead of print.
39.
Fleddermann M, Demmelmair H, Grote V, Nikolic T, Trisic B, Koletzko B: Infant formula composition affects energetic efficiency for growth: the BeMIM study, a randomized controlled trial. Clin Nutr 2014;33:588-595.
40.
Uhl O, Fleddermann M, Hellmuth C, Demmelmair H, Koletzko B: Phospholipid species in newborn and 4 month old infants after consumption of different formulas or breast milk. PLoS One 2016;11:e0162040.
41.
Rodriguez G, Iglesia I, Bel-Serrat S, Moreno LA: Effect of n-3 long chain polyunsaturated fatty acids during the perinatal period on later body composition. Br J Nutr 2012;107(suppl 2):S117-S128.
42.
Muhlhausler BS, Gibson RA, Makrides M: Effect of long-chain polyunsaturated fatty acid supplementation during pregnancy or lactation on infant and child body composition: a systematic review. Am J Clin Nutr 2010;92:857-863.
43.
Mennitti LV, Oliveira JL, Morais CA, Estadella D, Oyama LM, Oller do Nascimento CM, et al: Type of fatty acids in maternal diets during pregnancy and/or lactation and metabolic consequences of the offspring. J Nutr Biochem 2015;26:99-111.
44.
Zhou SJ, Sullivan T, Gibson RA, Lönnerdal B, Prosser CG, Lowry DJ, et al: Nutritional adequacy of goat milk infant formulas for term infants: a double-blind randomised controlled trial. Br J Nutr 2014;111:1641-1651.
45.
Demmelmair H, Koletzko B: Variation of metabolite and hormone contents in human milk. Clin Perinatol 2017;44:151-164.
46.
Tai CC, Ding ST: N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem 2010;21:357-363.
47.
Mohorko N, Petelin A, Jurdana M, Biolo G, Jenko-Pražnikar Z: Elevated serum levels of cysteine and tyrosine: early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome. Biomed Res Int 2015;2015:418681.
48.
Butte NF, Brandt ML, Wong WW, Liu Y, Mehta NR, Wilson TA, et al: Energetic adaptations persist after bariatric surgery in severely obese adolescents. Obesity (Silver Spring) 2015;23:591-601.
49.
McCormack SE, Shaham O, McCarthy MA, Deik AA, Wang TJ, Gerszten RE, et al: Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes 2013;8:52-61.
50.
Newbern D, Gumus Balikcioglu P, Balikcioglu M, Bain J, Muehlbauer M, Stevens R, et al: Sex differences in biomarkers associated with insulin resistance in obese adolescents: metabolomic profiling and principal components analysis. J Clin Endocrinol Metab 2014;99:4730-4739.
51.
Perng W, Gillman MW, Fleisch AF, Michalek RD, Watkins SM, Isganaitis E, et al: Metabolomic profiles and childhood obesity. Obesity (Silver Spring) 2014;22:2570-2578.
52.
Lee A, Jang HB, Ra M, Choi Y, Lee HJ, Park JY, et al: Prediction of future risk of insulin resistance and metabolic syndrome based on Korean boy's metabolite profiling. Obes Res Clin Pract 2015;9:336-345.
53.
Wiklund P, Zhang X, Tan X, Keinänen-Kiukaanniemi S, Alen M, Cheng S: Serum amino acid profiles in childhood predict triglyceride level in adulthood: a 7-year longitudinal study in girls. J Clin Endocrinol Metab 2016;101:2047-2055.
54.
Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, et al: Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts 2012;5:660-670.
55.
Hellmuth C, Kirchberg FF, Lass N, Harder U, Peissner W, Koletzko B, et al: Tyrosine is associated with insulin resistance in longitudinal metabolomic profiling of obese children. J Diabetes Res 2016;2016:2108909.
56.
Michaliszyn SF, Sjaarda LA, Mihalik SJ, Lee S, Bacha F, Chace DH, et al: Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab 2012;97:E2119-E2124.
57.
Mihalik SJ, Michaliszyn SF, De Las Heras J, Bacha F, Lee S, Chace DH, et al: Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care 2012;35:605-611.
58.
O'Connell TM: The complex role of branched chain amino acids in diabetes and cancer. Metabolites 2013;3:931-945.
59.
Marchesini G, Bianchi GP, Vilstrup H, Capelli M, Zoli M, Pisi E: Elimination of infused branched-chain amino-acids from plasma of patients with non-obese type 2 diabetes mellitus. Clin Nutr 1991;10:105-113.
60.
Serralde-Zúñiga AE, Guevara-Cruz M, Tovar AR, Herrera-Hernández MF, Noriega LG, Granados O, et al: Omental adipose tissue gene expression, gene variants, branched-chain amino acids, and their relationship with metabolic syndrome and insulin resistance in humans. Genes Nutr 2014;9:431.
61.
Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al: Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17:448-453.
62.
Steffen LM, Vessby B, Jacobs DR Jr, Steinberger J, Moran A, Hong CP, et al: Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents. Int J Obes (Lond) 2008;32:1297-1304.
63.
Butte NF, Liu Y, Zakeri IF, Mohney RP, Mehta N, Voruganti VS, et al: Global metabolomic profiling targeting childhood obesity in the Hispanic population. Am J Clin Nutr 2015;102:256-267.
64.
Elizondo-Montemayor L, Serrano-González M, Ugalde-Casas PA, Cuello-García C, Borbolla-Escoboza JR: Plasma phospholipid fatty acids in obese male and female Mexican children. Ann Nutr Metab 2010;57:234-241.
65.
Karlsson M, Mårild S, Brandberg J, Lönn L, Friberg P, Strandvik B: Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents. Obesity (Silver Spring) 2006;14:1931-1939.
66.
Saito E, Okada T, Abe Y, Kuromori Y, Miyashita M, Iwata F, et al: Docosahexaenoic acid content in plasma phospholipids and desaturase indices in obese children. J Atheroscler Thromb 2011;18:345-350.
67.
Wolters M, Schlenz H, Börnhorst C, Risé P, Galli C, Moreno LA, et al: Desaturase activity is associated with weight status and metabolic risk markers in young children. J Clin Endocrinol Metab 2015;100:3760-3769.
68.
Paton CM, Ntambi JM: Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab 2009;297:E28-E37.
69.
Braverman NE, Moser AB: Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 2012;1822:1442-1452.
70.
Zheng H, Yde CC, Arnberg K, Mølgaard C, Michaelsen KF, Larnkjær A, et al: NMR-based metabolomic profiling of overweight adolescents: an elucidation of the effects of inter-/intraindividual differences, gender, and pubertal development. Biomed Res Int 2014;2014:537157.
71.
Wallace M, Hashim YZ, Wingfield M, Culliton M, McAuliffe F, Gibney M, et al: Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. Hum Reprod 2010;25:949-956.
72.
Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, et al: Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 2011;7:e1002215.
73.
Ruoppolo M, Campesi I, Scolamiero E, Pecce R, Caterino M, Cherchi S, et al: Serum metabolomic profiles suggest influence of sex and oral contraceptive use. Am J Transl Res 2014;6:614-624.
74.
Sitruk-Ware R, Nath A: Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord 2011;12:63-75.
75.
Moller SE, Moller BM, Olesen M, Fjalland B: Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle. Eur J Clin Pharmacol 1996;50:179-184.
76.
Wiklund P, Zhang X, Tan X, Keinänen-Kiukaanniemi S, Alen M, Cheng S: Serum amino acid profiles in childhood predict triglyceride level in adulthood: a 7-year longitudinal study in girls. J Clin Endocrinol Metab 2016;101:2047-2055.
77.
Gluckman PD, Hanson MA, Cooper C, Thornburg KL: Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61-73.
78.
Oddy WH, Mori TA, Huang RC, Marsh JA, Pennell CE, Chivers PT, et al: Early infant feeding and adiposity risk: from infancy to adulthood. Ann Nutr Metab 2014;64:262-270.
79.
Owen CG, Martin RM, Whincup PH, Smith GD, Cook DG: Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence. Pediatrics 2005;115:1367-1377.
80.
Rauschert S, Uhl O, Koletzko B, Hellmuth C: Metabolomic biomarkers for obesity in humans: a short review. Ann Nutr Metab 2014;64:314-324.
81.
Rauschert S, Uhl O, Koletzko B, Kirchberg F, Mori TA, Huang RC, et al: Lipidomics reveals associations of phospholipids with obesity and insulin resistance in young adults. J Clin Endocrinol Metab 2016;101:871-879.
82.
Muhlhausler B, Smith SR: Early-life origins of metabolic dysfunction: role of the adipocyte. Trends Endocrinol Metab 2009;20:51-57.
83.
Unger RH: Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003;14:398-403.
84.
Corcoran MP, Lamon-Fava S, Fielding RA: Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am J Clin Nutr 2007;85:662-677.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.